129 related articles for article (PubMed ID: 11019439)
21. HIV-1 drug resistance and mother-to-child transmission.
Morris L; Pillay C; Gray G; McIntyre J
SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
[TBL] [Abstract][Full Text] [Related]
22. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Ann N Y Acad Sci; 2000 Nov; 918():53-6. PubMed ID: 11131734
[No Abstract] [Full Text] [Related]
23. From PMTCT to a more comprehensive AIDS response for women: a much-needed shift.
Eyakuze C; Jones DA; Starrs AM; Sorkin N
Dev World Bioeth; 2008 Apr; 8(1):33-42. PubMed ID: 18315723
[TBL] [Abstract][Full Text] [Related]
24. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
Cohen J
Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
[No Abstract] [Full Text] [Related]
25. [The UN Millennium Project; especially the prevention and treatment of the HIV-virus and AIDS in order to reduce child and maternal mortality].
van Dillen J; Stekelenburg J; van Roosmalen J
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1413-7. PubMed ID: 16841592
[TBL] [Abstract][Full Text] [Related]
26. Preventing mother-to-infant transmission of HIV in the developing world.
Laurence J
AIDS Read; 1999 Oct; 9(7):448-9, 496. PubMed ID: 12737134
[No Abstract] [Full Text] [Related]
27. Unequal care sustains vertical transmission rate.
Kasper T
GMHC Treat Issues; 1999 Feb; 13(2):11-2. PubMed ID: 11366115
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
29. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
30. [Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants].
Schlösser R; Linde R; Dunsch D; Reitter A; Haberl A; Bauer K
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):230-5. PubMed ID: 18176903
[TBL] [Abstract][Full Text] [Related]
31. AIDS in Africa among women and infants: a human rights framework.
Gostin LO
Hastings Cent Rep; 2002; 32(5):9-10. PubMed ID: 12360777
[No Abstract] [Full Text] [Related]
32. Perinatal transmission.
AIDS Policy Law; 1999 Sep; 14(17):12. PubMed ID: 11366827
[TBL] [Abstract][Full Text] [Related]
33. Update on preventing vertical transmission of HIV type 1.
Chen F; Pau AK; Piscitelli SC
Am J Health Syst Pharm; 2000 Sep; 57(17):1616-23. PubMed ID: 10984815
[No Abstract] [Full Text] [Related]
34. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E
Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822
[TBL] [Abstract][Full Text] [Related]
35. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
37. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
[TBL] [Abstract][Full Text] [Related]
38. Routine provision of nevirapine to women of unknown serostatus: at best a temporary solution to prevent MTCT.
Newell ML
Bull World Health Organ; 2005 Mar; 83(3):228-9. PubMed ID: 15798848
[No Abstract] [Full Text] [Related]
39. Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
Sint TT; Dabis F; Kamenga C; Shaffer N; de Zoysa IF
Bull World Health Organ; 2005 Mar; 83(3):224-8. PubMed ID: 15798847
[TBL] [Abstract][Full Text] [Related]
40. HIV: mother to child transmission.
Volmink J; Mahlat U
Clin Evid; 2005 Jun; (13):823-33. PubMed ID: 16135280
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
